Schonfeld Strategic Advisors LLC Sells 344,207 Shares of Alpha Teknova, Inc. (NASDAQ:TKNO)

Schonfeld Strategic Advisors LLC cut its holdings in shares of Alpha Teknova, Inc. (NASDAQ:TKNO - Free Report) by 93.9% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 22,193 shares of the company's stock after selling 344,207 shares during the period. Schonfeld Strategic Advisors LLC's holdings in Alpha Teknova were worth $185,000 at the end of the most recent quarter.

A number of other large investors also recently modified their holdings of TKNO. NewEdge Advisors LLC lifted its stake in Alpha Teknova by 14.3% in the fourth quarter. NewEdge Advisors LLC now owns 15,632 shares of the company's stock worth $131,000 after purchasing an additional 1,953 shares during the last quarter. JPMorgan Chase & Co. raised its position in Alpha Teknova by 622.5% in the fourth quarter. JPMorgan Chase & Co. now owns 4,400 shares of the company's stock worth $37,000 after acquiring an additional 3,791 shares during the period. Mount Lucas Management LP purchased a new position in Alpha Teknova during the fourth quarter valued at $75,000. Northern Trust Corp grew its stake in Alpha Teknova by 31.5% during the fourth quarter. Northern Trust Corp now owns 39,196 shares of the company's stock valued at $327,000 after acquiring an additional 9,383 shares in the last quarter. Finally, China Universal Asset Management Co. Ltd. purchased a new position in shares of Alpha Teknova in the 4th quarter worth $94,000. 13.81% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Separately, Craig Hallum started coverage on shares of Alpha Teknova in a research report on Monday, February 10th. They issued a "buy" rating and a $12.00 price objective on the stock.

Alpha Teknova Stock Performance

NASDAQ:TKNO traded down $0.07 during midday trading on Tuesday, reaching $6.48. The stock had a trading volume of 14,947 shares, compared to its average volume of 405,711. The stock has a market cap of $346.03 million, a P/E ratio of -8.75 and a beta of 0.50. Alpha Teknova, Inc. has a 12-month low of $1.15 and a 12-month high of $10.37. The firm has a fifty day simple moving average of $5.87 and a two-hundred day simple moving average of $7.10. The company has a quick ratio of 3.94, a current ratio of 4.73 and a debt-to-equity ratio of 0.12.

Alpha Teknova (NASDAQ:TKNO - Get Free Report) last posted its quarterly earnings data on Thursday, May 8th. The company reported ($0.09) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.11) by $0.02. Alpha Teknova had a negative net margin of 87.17% and a negative return on equity of 35.30%. The company had revenue of $9.60 million for the quarter, compared to analyst estimates of $9.41 million. On average, equities analysts expect that Alpha Teknova, Inc. will post -0.58 EPS for the current year.

Alpha Teknova Company Profile

Alpha Teknova, Inc produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification.